Biocom CRO Workshop: Dr. Aruna Somasiri on Utilization of IHC in Novel Biomarker Identification
The Importance of IHC in Biomarker Analysis & Discovery
Biomarkers play an important role in preclinical studies, identifying potential drug targets, and preventing toxicities. IHC is critical in determining biomarker detection, localization, and semi-quantitative expression levels. Through multi-panel IHC testing, one can determine the expression of multiple biomarkers in a biopsied sample with a high level of sensitivity and specificity. Dr. Somasiri will expand on the topic of IHC and biomarker analysis and discovery during the Biocom CRO workshop in April.
Biocom CRO Workshop: Technologies for Discovering & Analyzing Novel Biomarkers
The Biocom CRO workshop will focus on strategies for discovering and analyzing novel biomarkers using three distinct technologies: immunohistochemical, bioanalytical, and genomic approaches. The full speaker panel for this workshop is as follows:
- Aruna Somasiri, PhD. MBA: President, Wax-it Histology Services, Inc.
- Dan Kassel, PhD: Founder and CEO, SciAnalytical
- Jeffrey Shaman, Ph.D.: Business Development Lead, Translational Genomics, GeneWiz
Request a Complimentary Consultation
To discuss your study requiring immunohistochemistry, contact Wax-it Histology Services via email at info@waxitinc.com or by phone at 604.822.1595 for a complimentary scientific consultation.
About Wax-it Histology Services, Inc.
Incorporated in 2003, Wax-it Histology Services, Inc. brings a wealth of knowledge to our internationally recognized pharmaceutical, biotechnology, and medical device partners. Wax-it Histology Services, Inc. is a GLP-recognized CRO that offers general histology services (paraffin and frozen), immunohistochemistry services (general IHC, cross-reactivity studies, antibody and biomarker testing/validation), GLP and non-GLP histopathology for preclinical toxicology studies, and resin/plastic sectioning for implantable medical devices and bone.